RECURRENT OR METASTATIC SOLID TUMORS
Clinical trials for RECURRENT OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for RECURRENT OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug enhertu gets a shot in the arm: new Under-the-Skin version tested
Disease control Recruiting nowThis early-phase trial is testing a new way to give the cancer drug T-DXd (Enhertu) — as a shot under the skin instead of an IV drip. The study will enroll 76 adults with metastatic solid tumors to find the safest dose and see how well the body handles it. Researchers will also c…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug targets 13 cancers in major trial
Disease control Recruiting nowThis study tests a drug called ifinatamab deruxtecan (I-DXd) in people with 13 types of advanced solid tumors that have come back or spread. The trial aims to see how well the drug shrinks tumors and what side effects it causes. About 520 participants will receive the drug intrav…
Matched conditions: RECURRENT OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC